STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas.

2018-09-12

Abstract

The motile characteristics and mechanisms that drive the dissemination of diffuse large B-cell lymphoma (DLBCL) are elusive. Here, we show that DLBCL initiates dissemination through activating STAT3-mediated amoeboid migration. Mechanistically, STAT3 activates RHOH transcription, which competes with the RhoGDP dissociation inhibitor RhoGDIγ to activate RhoA. In addition, activated STAT3 regulates microtubule dynamics and releases ARHGEF2 to activate RhoA. Both the JAK inhibitor ruxolitinib and the microtubule stabilizer Taxol suppress DLBCL cell dissemination in vivo. A clinical DLBCL sample analysis shows that STAT3-driven amoeboid movement is particularly important for the transition from stage I to stage II. This study elucidates the mechanism of DLBCL dissemination and progression and highlights the potential of combating advanced DLBCL with a JAK/STAT inhibitor or microtubule stabilizer to reduce DLBCL motility; these findings may have a great impact on the development of patient-tailored treatments for DLBCL.


STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas - PubMed (nih.gov) 

免費建立您的網站! 此網站是在 Webnode 上建立的。今天開始免費建立您的個人網站 立即開始
我們使用了 cookies 來確保我們網站的運作正常與安全性,並為您提供最佳的使用體驗。

進階設定

您可以在此自訂您的 cookie 偏好。啟用或關閉以下這些類別,並儲存您的選擇。